Skip to content
★ Sign in to follow
王

王徵

Executive
Shanghai Bao Pharmaceuticals Co., Ltd. - B - H Shares
Insider activity · 24 months1 buy0 salesCumulative net flow
Total declarations
5
Company
1
▲ Purchases (5 ops.)
€821k
▼ Sales (0 ops.)
—

Latest filing published 28 Oct 2026 for Shanghai Bao Pharmaceuticals Co., Ltd. - B - H Shares, €45k.

Filing timeline

BuySale
王徵

Insider track record

Disclosed buys
5
Disclosed sells
0
Signal history

Closed purchases

Market purchases
5

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

王徵: trading record in brief

王徵 is a declared insider of Shanghai Bao Pharmaceuticals Co., Ltd. - B - H Shares, with filings sourced from HKEX. Over a trading history stretching from 15 May 2026 to 27 October 2026, the count stands at 5 filings.

On the market, this insider has only ever bought: 5 purchases, €821k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

In size, the median ticket on the buying side is €99k. Scaled by market value, the purchases weigh a median 0.025% of market cap (sample: 3 purchases). 5 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The latest filing, published on 28 October 2026, reports an open-market purchase of €45k in Shanghai Bao Pharmaceuticals Co., Ltd. - B - H Shares. The median gap between a trade and its publication by HKEX is 2 days. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.

Companies and markets linked to 王徵

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total

5 of 1 declaration